A randomized double-blind and placebo-controlled clinical trial of Acupoint Application on spleen deficiency and wet resistance simple obesity

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: treatment group:Acupoint application of traditional Chinese Medicine;control group:Placebo Acupoint Application; CONDITION: Simple obesity PRIMARY OUTCOME: TCM syndrome score;Fat percentage;WC;BMI;WHR; SECONDARY OUTCOME: Visceral fat area;Fasting blood glucose;IWQOL‐Lite;blood fat; INCLUSION CRITERIA: 1) Meet the diagnostic criteria of simple obesity, and 28 = BMI = 40; 2) Conform to the syndrome differentiation standard of spleen deficiency dampness resistance type; 3) Age 18 50 years old; 4) No other weight loss measures other than lifestyle intervention have been taken in recent 3 months; 5) The patient has normal vital signs, knows the research plan, agrees to cooperate with the test, and signs a written informed consent.
Epistemonikos ID: adf201a6c0240f7e072ca680118d5ab04789cb86
First added on: Aug 26, 2024